App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.

André Miguel; Nicole Akana; Rachel Ryan; Alex Schmidt; Sean E Hovland; Brian Connor Stark; Sierra Colletto; Abigail Bowen; Nicole M. Rodin; Crystal Lederhos Smith; Sterling McPherson

doi:10.1037/pha0000790

June 1, 2026Experimental and Clinical PsychopharmacologyOpen Access

App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the feasibility and acceptability of an app-based intervention combined with varenicline for reducing heavy drinking days among smokers.
Phase I analog trial design
Participants received varenicline and app-based contingency management
Evaluated feasibility, acceptability, and initial efficacy indicators
The intervention was feasible and well accepted among participants.
Initial efficacy signals indicated a reduction in heavy drinking and cigarette smoking days.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Shows efficacy indicators for reducing heavy drinking in smokers, suggesting a novel treatment approach.

Abstract

< .01). The combination of VC and app-based CM was shown to be feasible and well accepted, with an initial signal of efficacy to reduce heavy-drinking and cigarette smoking. This combined therapeutic may provide a novel approach to treat tobacco smoking and AUD concomitantly. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Miguel et al. (2026) studied this question.

synapsesocial.com/papers/6a377edf24f042ddf4c59d0a https://doi.org/10.1037/pha0000790

View Full Paper

Ask AI

Bookmark

Share

App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading